← Mechanisms of action
APOA1
SINGLE PROTEINHomo sapiens
Preferred name: Apolipoprotein A-I ChEMBL ↗
Linked proteins
Drugs acting on this target (12)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| XMMEN-0E5 | Adcc | experimental | mAb | APOA1 adcc |
| dii235 | Antisense inhibitor | experimental | Nucleic acid | APOA1 antisense inhibitor |
| ly3819469 | Antisense inhibitor | experimental | Nucleic acid | APOA1 antisense inhibitor |
| pelacarsen | Antisense inhibitor | experimental | Nucleic acid | APOA1 antisense inhibitor |
| apl180 | Inhibitor | experimental | Peptide | APOA1 inhibitor |
| ionis-apo(a)-lrx | Inhibitor | experimental | Nucleic acid | APOA1 inhibitor |
| mdco-216 | Inhibitor | experimental | Recombinant protein | APOA1 inhibitor |
| muvalaplin | Inhibitor | experimental | Small molecule | APOA1 inhibitor |
| sln360 | Inhibitor | experimental | Nucleic acid | APOA1 inhibitor |
| apolipoprotein | Supplementation | experimental | Biological | APOA1 supplementation |
| cer-001 | Supplementation | experimental | Recombinant protein | APOA1 supplementation |
| ri-001 | Supplementation | experimental | Recombinant protein | APOA1 supplementation |